UNIGE document Professional Article
previous document  unige:106804  next document
add to browser collection
Title

Ostéoporose

Authors
Published in Revue médicale suisse. 2018, vol. 14, no. 588-589, p. 70-73
Abstract The risk for a second fracture within two years after a first one is high. Ten years denosumab treatment show favorable results with a risk of early vertebral fractures in patients with prevalent vertebral fractures when treatment is stopped. Teriparatide is more effective than risedronate to prevent vertebral and clinical fractures in high risk patients. Romosozumab acts as an anabolic agent in osteoporosis. Atypical femoral fractures associated with bisphosphonate treatment could be more frequent in patients with particular anatomical features. Management of osteoporosis treatment depends on the drug which is used and on the risk of fracture of the patient.
Identifiers
PMID: 29337454
Full text
Article (Published version) (165 Kb) - public document Free access
Structures
Research group Génétique des ostéoporoses (544)
Citation
(ISO format)
UEBELHART, Brigitte Florence, FERRARI, Serge Livio. Ostéoporose. In: Revue médicale suisse, 2018, vol. 14, n° 588-589, p. 70-73. https://archive-ouverte.unige.ch/unige:106804

60 hits

17 downloads

Update

Deposited on : 2018-08-03

Export document
Format :
Citation style :